Securities fraud
Search documents
SEMR Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Semrush Holdings, Inc. is Fair to Shareholders
Businesswire· 2025-11-19 14:08
Nov 19, 2025 9:08 AM Eastern Standard TimeSEMR Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Semrush Holdings, Inc. is Fair to ShareholdersShareShareholders should contact the firm immediately as there may be limited time to enforce your rights.NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Semrush Holdings, Inc. (NYSE: SEMR) to Adobe for $12.00 per share is fair to Semrush shareholders.Halper Sadeh encourages Semrush share ...
Important Notice to Long-Term Shareholders of enCore Energy Corp. (EU): Grabar Law Officer is Investigating Claims on Your Behalf
Newsfile· 2025-11-19 14:04
Core Insights - Grabar Law Office is investigating claims on behalf of shareholders of enCore Energy Corp. regarding potential breaches of fiduciary duties by certain officers and directors [1] - Shareholders who purchased enCore Energy Corp. shares prior to March 28, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2] - A securities fraud class action complaint alleges that enCore Energy Corp. made materially false and misleading statements and failed to disclose adverse facts about its business and operations [3] Company Details - The investigation focuses on whether enCore Energy Corp.'s officers failed to disclose that the company lacked effective internal controls over financial reporting [3] - The complaint also states that enCore could not capitalize certain exploratory and development costs under GAAP, leading to increased net losses [3] - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially misleading [3]
JHX STOCK: James Hardie Industries plc Sued for Securities Fraud after Destocking Issues Cause 34% Stock Drop -- Investors Notified to Contact BFA Law by December 23 Deadline
Globenewswire· 2025-11-19 13:08
Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Allegations of Fraud - The lawsuit claims that James Hardie misled investors by stating that its North American fiber cement segment showed "inherent strength" and "underlying momentum," while in reality, sales were inflated due to inventory loading by channel partners, indicating fraudulent channel stuffing rather than genuine customer demand [5]. Stock Performance and Impact - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers. This revelation led to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 within a day [6].
BRBR STOCK: BellRing Brands Investigated for Securities Fraud after Inventory Levels Cause 18% Stock Drop -- Investors Notified to Contact BFA Law
Globenewswire· 2025-11-19 13:08
Core Viewpoint - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, with concerns regarding the sustainability of its sales growth driven by temporary trade inventory loading rather than genuine consumer demand [1][2]. Company Overview - BellRing Brands operates in the convenient nutrition category, primarily known for its brands Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders [2]. Sales Performance - The company reported that Premier Protein achieved an all-time high in household penetration and strong demand across all channels, attributed to distribution expansion and promotional activities [2]. - However, the actual sales growth may have been artificially inflated due to temporary inventory loading at key retailers, raising questions about the sustainability of this growth [2]. Stock Market Reaction - On May 5, 2025, BellRing disclosed that several key retailers had reduced their inventory levels, which would negatively impact growth in Q3 2025. Following this announcement, the stock price dropped by $13.96, or over 18%, from $77.34 to $63.38 per share [3]. - On August 4, 2025, the company announced disappointing quarterly consumption figures for Premier Protein RTD Shakes, leading to a further decline in stock price by $17.46, or nearly 33%, from $53.64 to $36.18 per share [4].
LRN STOCK: Stride, Inc. Sued for Securities Fraud after Low Enrollments Cause 50% Stock Drop -- Investors Notified to Contact BFA Law by January 12 Deadline
Globenewswire· 2025-11-19 13:08
Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][2]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [3]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students," failed to comply with employee background checks and licensure laws, and experienced poor customer service leading to higher withdrawal rates and lower conversion rates [3][4]. Stock Performance - On September 14, 2025, Stride's stock dropped by $18.60, or over 11%, from $158.36 to $139.76 per share following the fraud allegations [4]. - On October 28, 2025, Stride acknowledged that poor customer experience led to an estimated 10,000-15,000 fewer enrollments, causing the stock to plummet by $83.48, or more than 54%, from $153.53 to $70.05 per share [5].
KMX STOCK: CarMax, Inc. Sued for Securities Fraud after Demand Issues and CEO Departure Cause 24% Stock Drop -- Investors Notified to Contact BFA Law by January 2 Deadline
Globenewswire· 2025-11-19 13:08
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit. In ...
COTY STOCK: Coty Inc. Investigated for Securities Fraud after Excess Inventory Levels Cause 21% Stock Drop -- Investors Notified to Contact BFA Law
Globenewswire· 2025-11-19 13:08
Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenue [2]. Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and headwinds from previous fiscal year innovations. The company noted a slowdown in cosmetics sales due to various factors, including value-seeking behavior and U.S.-specific challenges [3]. - Following the announcement of these results, Coty's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share [3].
INSP STOCK: Inspire Medical Systems, Inc. Sued for Securities Fraud after Inspire V Delays Cause 32% Stock Drop -- Investors Notified to Contact BFA Law by January 5 Deadline
Globenewswire· 2025-11-19 13:08
Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Minnesota, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until January 5, 2026, to request to lead the case [3]. Group 2: Company Background - Inspire Medical Systems develops and manufactures an implantable medical device for treating sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Group 3: Allegations and Stock Impact - Inspire allegedly misled investors by claiming it had taken necessary steps for the launch of Inspire V, while in reality, it failed to prepare clinicians and payors, leading to delays and weak demand [5][6]. - On August 4, 2025, Inspire announced an "elongated timeframe" for the Inspire V launch and reduced its 2025 earnings per share guidance by over 80%, causing the stock price to drop by $42.04, or more than 32%, from $129.95 to $87.91 per share [7][8].
FCX STOCK: Freeport-McMoRan Inc. Sued for Securities Fraud after Safety Issues Cause 25% Stock Drop -- Investors Notified to Contact BFA Law by January 12 Deadline
Globenewswire· 2025-11-19 13:07
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-clas ...
PRGO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Globenewswire· 2025-11-19 11:00
Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Company Overview - Perrigo provides over-the-counter health and wellness solutions and acquired Nestlé's Gateway infant formula plant and the rights to the Good Start® brand for $170 million in November 2022 [2]. Allegations of Misleading Statements - The lawsuit alleges that Perrigo failed to disclose significant underinvestment in the acquired infant formula business, which required substantial capital expenditures beyond initial estimates to address operational deficiencies [3]. - Specific allegations include manufacturing deficiencies and overstated financial results, including earnings and cash flow [3]. Financial Impact and Stock Performance - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, leading to a 50% decline in earnings per share compared to the previous year [4]. - Following this announcement, Perrigo's stock price fell over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [5]. - On August 6, 2025, adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an over 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and slashed its fiscal year 2025 outlook, leading to a more than 25% drop in stock price [7]. Legal Process - Investors who purchased Perrigo securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to act on behalf of other class members [8][9].